Share

June 2013; 3 (3) Practice Across Borders

Standard strategies for acute ischemic stroke within the rtPA therapeutic window

GraphicFinland

Turgut Tatlisumak
First published June 10, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e318296f120
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
73

Share

Article Information

vol. 3 no. 3 206-208
DOI: 
https://doi.org/10.1212/CPJ.0b013e318296f120
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published June 10, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Turgut Tatlisumak, MD, PhD
  1. Turgut Tatlisumak, MD, PhD
    2. Scientific Advisory Boards:

    1. Boehringer-Ingelheim Mitsubishi Pharma PhotoThera BrainsGate H. Lundbeck A/S Orion Pharma

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Boehringer Ingelheim (travel expenses to 1 conference) Professio Finland (speaker honoraria) University of Helsinki (speaker honoraria) Finnish Medical Association (speaker honoraria) University of Donau (Austria, speaker honoraria) Genzyme Oy (Finland, speaker honoraria) Finnish Neurological Association (speaker honoraria) Australia-NZ Stroke Association (speaker honoraria) Congress traveling and accommodation costs: European Stroke Conference European Federation of Neurological Societies European Stroke Organisation L’ANTEL telemedicine conference (France) University of Rostock (Germany) University of Bielefeld (Germany) SITS International Boehringer Ingelheim University of Donau (Austria) Catholic University of Leuven (Belgium) Austrian Stroke Society University of Oulu (Finland) Nordic Stroke Conference Australia-NZ Stroke Association

    Editorial Boards:

    1. Stroke, 2000-2006, 2010- Current Vascular Pharmacology, 2002- The Open Pharmacology Journal 2007-2010 Clinics of Turkey 2007- Clinics of Turkey / Neurology 2007- The Open Cardiovascular Medicine Journal 2007- Recent Patents on Biotechnology 2008- Recent Patents on CNS Drug Discovery, 2008-2010 Experimental and Translational Stroke Medicine, 2008-2009 Stroke Research and Treatment, 2009- BMC Journal of Experimental and Translational Stroke Medicine, 2009- Frontiers in Stroke, 2010- Case Reports in Neurology (founding editor-in-chief)2009- 2012 Cerebrovascular Diseases, 2011- No compensation was received for any of the above editorial duties

    Patents:

    1. 1. Stanniocalcin proteins and nucleic acids and methods based thereon. Application No/ Patent No: WO0130969, Publication date: 2001-05-03, requested patent: EP1233778, Inventors: Olsen HS, Zhang K, Lindsberg P, Tatlisumak T, Kaste M, Andersson LC. Human Genome Sciences Inc (US), Application number: WO2000US29432 200001026 2. New Therapeutic Uses (method to prevent brain edema and reperfusion injury), PCT/FI2004/000070. Inventors: Lindsberg PJ, Karjalainen-Lindsberg M-L, Tatlisumak T, Strbian D. Applicant: Licentia Oy. Application date: February 13, 2003. Publication 7/2003, Application number: 20030224. 3. Thrombolytic compositions (method to prevent postthrombolytic hemorrhage formation), PCT/FI2004/000071. Inventors: Lindsberg PJ, Karjalainen- Lindsberg M-L, Tatlisumak T, Strbian D, Kovanen P. Applicant: Licentia Oy. Application date: February 13, 2003. Publication: 3/2003. Application number: 20030225.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Boehringer Ingelheim, PhotoThera, BrainsGate, H. Lundbeck A/B, Orion

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. I was in capacity of receiving for editing 1 book for Cambridge Univ Press (donated to British Red Cross) and being an editor-in-chief for Case Reports in Neurology Journal (donated to Swiss Red Cross).

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Helsinki University Central Hospital Research Funds European Union, EU FP7 202213, 2008-2012, PI Biocentrum Finland, 2010-2012 Biocentrum Helsinki, 2011, 2012, 2013 Finnish Academy of Sciences, 2012-2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Sigrid Juselius Foundation, 2010, PI Maire Taponen Foundation, 2012

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland:
  1. Correspondence to:
    turgut.tatlisumak{at}hus.fi
View Full Text

Article usage

Article usage: May 2013 to July 2022

AbstractFullPdfSource
May 2013121Highwire
Jun 2013110623Highwire
Jul 20138146Highwire
Aug 20133007Highwire
Sep 20132210Highwire
Oct 20131631Highwire
Nov 20131212Highwire
Dec 20133701Highwire
Jan 20144802Highwire
Feb 20143210Highwire
Mar 20141611Highwire
Apr 20143500Highwire
May 20141701Highwire
Jun 20141600Highwire
Jul 2014200Highwire
Aug 2014500Highwire
Sep 20141401Highwire
Oct 2014602Highwire
Nov 2014601Highwire
Dec 2014500Highwire
Jan 20151001Highwire
Feb 2015400Highwire
Mar 20151401Highwire
Apr 2015410Highwire
May 2015720Highwire
Jun 2015600Highwire
Jul 2015400Highwire
Aug 2015300Highwire
Sep 2015502Highwire
Oct 20151201Highwire
Nov 20152800Highwire
Dec 20154000Highwire
Jan 20163300Highwire
Feb 20161200Highwire
Mar 2016100Highwire
Apr 2016401Highwire
May 2016600Highwire
Jun 2016400Highwire
Jul 2016400Highwire
Aug 2016600Highwire
Sep 2016900Highwire
Oct 20161500Highwire
Nov 2016901Highwire
Dec 20161000Highwire
Jan 2017800Highwire
Feb 2017500Highwire
Mar 2017300Highwire
Apr 2017500Highwire
May 2017700Highwire
Jul 2017100Highwire
Aug 20171010Highwire
Sep 2017200Highwire
Oct 2017300Highwire
Nov 2017500Highwire
Dec 2017900Highwire
Jan 2018600Highwire
Feb 20181000Highwire
Mar 20181710Highwire
Apr 20181301Highwire
Apr 2018121pmc
May 20181700Highwire
Jun 20181100Highwire
Jun 2018022pmc
Jul 20181500Highwire
Aug 20181800Highwire
Aug 2018121pmc
Sep 2018900Highwire
Oct 2018800Highwire
Nov 2018900Highwire
Dec 2018500Highwire
Jan 20191100Highwire
Feb 2019300Highwire
Mar 2019801Highwire
Apr 2019300Highwire
May 20191806Highwire
Jun 2019801Highwire
Jul 2019500Highwire
Sep 2019600Highwire
Oct 2019300Highwire
Nov 2019601Highwire
Dec 2019800Highwire
Jan 2020501Highwire
Feb 2020600Highwire
Mar 2020500Highwire
Apr 2020110Highwire
May 2020700Highwire
Jun 2020300Highwire
Jul 2020300Highwire
Aug 20202900Highwire
Sep 2020300Highwire
Oct 2020500Highwire
Nov 2020800Highwire
Dec 2020500Highwire
Jan 2021300Highwire
Feb 2021400Highwire
Mar 2021800Highwire
Apr 2021600Highwire
May 2021300Highwire
Jun 2021400Highwire
Jul 2021300Highwire
Aug 20211000Highwire
Sep 2021500Highwire
Oct 20211100Highwire
Nov 20211100Highwire
Dec 2021600Highwire
Jan 20221500Highwire
Feb 20221101Highwire
Mar 20221200Highwire
Apr 2022600Highwire
May 2022800Highwire
Jun 2022200Highwire
Jul 2022201Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me